232 related articles for article (PubMed ID: 11118325)
1. The RNA aptamer-binding site of hepatitis C virus NS3 protease.
Hwang J; Fauzi H; Fukuda K; Sekiya S; Kakiuchi N; Shimotohno K; Taira K; Kusakabe I; Nishikawa S
Biochem Biophys Res Commun; 2000 Dec; 279(2):557-62. PubMed ID: 11118325
[TBL] [Abstract][Full Text] [Related]
2. Specific RNA aptamers to NS3 protease domain of hepatitis C virus.
Fukuda K; Vishinuvardhan D; Sekiya S; Kakiuchi N; Shimotohno K; Kumar PK; Nishikawa S
Nucleic Acids Symp Ser; 1997; (37):237-8. PubMed ID: 9586087
[TBL] [Abstract][Full Text] [Related]
3. Analysis of aptamer binding site for HCV-NS3 protease by alanine scanning mutagenesis.
Hwang J; Fauzi H; Fukuda K; Sekiya S; Kakiuchi N; Taira K; Kusakabe I; Nishikawa S
Nucleic Acids Symp Ser; 2000; (44):253-4. PubMed ID: 12903364
[TBL] [Abstract][Full Text] [Related]
4. Redesigning the substrate specificity of the hepatitis C virus NS3 protease.
Failla CM; Pizzi E; De Francesco R; Tramontano A
Fold Des; 1996; 1(1):35-42. PubMed ID: 9079362
[TBL] [Abstract][Full Text] [Related]
5. Isolation of RNA aptamers specific to the NS3 protein of hepatitis C virus from a pool of completely random RNA.
Kumar PK; Machida K; Urvil PT; Kakiuchi N; Vishnuvardhan D; Shimotohno K; Taira K; Nishikawa S
Virology; 1997 Oct; 237(2):270-82. PubMed ID: 9356339
[TBL] [Abstract][Full Text] [Related]
6. Solution structure and backbone dynamics of an engineered arginine-rich subdomain 2 of the hepatitis C virus NS3 RNA helicase.
Liu D; Wang YS; Gesell JJ; Wyss DF
J Mol Biol; 2001 Nov; 314(3):543-61. PubMed ID: 11846566
[TBL] [Abstract][Full Text] [Related]
7. Use of the fused NS4A peptide-NS3 protease domain to study the importance of the helicase domain for protease inhibitor binding to hepatitis C virus NS3-NS4A.
Thibeault D; Massariol MJ; Zhao S; Welchner E; Goudreau N; Gingras R; Llinàs-Brunet M; White PW
Biochemistry; 2009 Feb; 48(4):744-53. PubMed ID: 19119853
[TBL] [Abstract][Full Text] [Related]
8. Rational design of dual-functional aptamers that inhibit the protease and helicase activities of HCV NS3.
Umehara T; Fukuda K; Nishikawa F; Kohara M; Hasegawa T; Nishikawa S
J Biochem; 2005 Mar; 137(3):339-47. PubMed ID: 15809335
[TBL] [Abstract][Full Text] [Related]
9. Designing and analysis of a potent bi-functional aptamers that inhibit protease and helicase activities of HCV NS3.
Umehara T; Fukuda K; Nishikawa F; Sekiya S; Kohara M; Hasegawa T; Nishikawa S
Nucleic Acids Symp Ser (Oxf); 2004; (48):195-6. PubMed ID: 17150545
[TBL] [Abstract][Full Text] [Related]
10. The hepatitis C virus NS3 proteinase: structure and function of a zinc-containing serine proteinase.
De Francesco R; Pessi A; Steinkühler C
Antivir Ther; 1998; 3(Suppl 3):99-109. PubMed ID: 10726060
[TBL] [Abstract][Full Text] [Related]
11. Critical point mutations for hepatitis C virus NS3 proteinase.
Yamada K; Mori A; Seki M; Kimura J; Yuasa S; Matsuura Y; Miyamura T
Virology; 1998 Jun; 246(1):104-12. PubMed ID: 9656998
[TBL] [Abstract][Full Text] [Related]
12. The hepatitis C virus encodes a serine protease involved in processing of the putative nonstructural proteins from the viral polyprotein precursor.
Eckart MR; Selby M; Masiarz F; Lee C; Berger K; Crawford K; Kuo C; Kuo G; Houghton M; Choo QL
Biochem Biophys Res Commun; 1993 Apr; 192(2):399-406. PubMed ID: 8387277
[TBL] [Abstract][Full Text] [Related]
13. Internal cleavage of hepatitis C virus NS3 protein is dependent on the activity of NS34A protease.
Yang SH; Lee CG; Song MK; Sung YC
Virology; 2000 Mar; 268(1):132-40. PubMed ID: 10683335
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C NS3 protease: restoration of NS4A cofactor activity by N-biotinylation of mutated NS4A using synthetic peptides.
Butkiewicz NJ; Yao N; Wright-Minogue J; Zhang R; Ramanathan L; Lau JY; Hong Z; Dasmahapatra B
Biochem Biophys Res Commun; 2000 Jan; 267(1):278-82. PubMed ID: 10623610
[TBL] [Abstract][Full Text] [Related]
15. An RNA ligand inhibits hepatitis C virus NS3 protease and helicase activities.
Fukuda K; Umehara T; Sekiya S; Kunio K; Hasegawa T; Nishikawa S
Biochem Biophys Res Commun; 2004 Dec; 325(3):670-5. PubMed ID: 15541341
[TBL] [Abstract][Full Text] [Related]
16. Structure/function analysis of an RNA aptamer for hepatitis C virus NS3 protease.
Sekiya S; Nishikawa F; Fukuda K; Nishikawa S
J Biochem; 2003 Mar; 133(3):351-9. PubMed ID: 12761171
[TBL] [Abstract][Full Text] [Related]
17. Product inhibition of the hepatitis C virus NS3 protease.
Steinkühler C; Biasiol G; Brunetti M; Urbani A; Koch U; Cortese R; Pessi A; De Francesco R
Biochemistry; 1998 Jun; 37(25):8899-905. PubMed ID: 9636031
[TBL] [Abstract][Full Text] [Related]
18. In trans interaction of hepatitis C virus helicase domains mediates protease activity critical for internal NS3 cleavage and cell transformation.
Pan RY; Hung TM; Kou YH; Chan NL; Chang MF; Chang SC
FEBS Lett; 2010 Feb; 584(3):482-6. PubMed ID: 19958771
[TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of RNA aptamers specific for the hepatitis C virus nonstructural protein 3 protease.
Fukuda K; Vishnuvardhan D; Sekiya S; Hwang J; Kakiuchi N; Taira K; Shimotohno K; Kumar PK; Nishikawa S
Eur J Biochem; 2000 Jun; 267(12):3685-94. PubMed ID: 10848986
[TBL] [Abstract][Full Text] [Related]
20. Generation of a novel poliovirus with a requirement of hepatitis C virus protease NS3 activity.
Hahm B; Back SH; Lee TG; Wimmer E; Jang SK
Virology; 1996 Dec; 226(2):318-26. PubMed ID: 8955051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
